TY - JOUR
T1 - Serial OX40 engagement on CD4+ T cells and natural killer T cells causes allergic airway inflammation
AU - Damayanti, Triya
AU - Kikuchi, Toshiaki
AU - Zaini, Jamal
AU - Daito, Hisayoshi
AU - Kanehira, Masahiko
AU - Kohu, Kazuyoshi
AU - Ishii, Naoto
AU - Satake, Masanobu
AU - Sugamura, Kazuo
AU - Nukiwa, Toshihiro
PY - 2010/4/1
Y1 - 2010/4/1
N2 - Rationale: OX40-OX40 ligand (OX40L) interactions have been proposed to support induction of allergic airway inflammation, which may be attributable to OX40 signaling in CD4+ helper T cells for adaptive immune responses. However, a possible involvement of natural killer T (NKT) cells in the pathogenesis suggests that the underlying mechanisms are not yet fully elucidated. Objectives: We aimed to characterize the OX40-modulated cellular contribution to allergic airway inflammation in a mouse model of house dust mite (HDM) allergen exposure. Methods: Mice were sensitized to HDM and, 3 weeks later, challenged with HDM on three consecutive days through the airways. Two days after the last exposure, bronchoalveolar lavage fluids and blood samples and lung tissues were evaluated for the airway inflammation. Measurements and Main Results: The development of HDM-induced eosinophilic airway inflammation was dependent on OX40 of both CD4+ T cells and NKT cells; OX40 engagement on CD4+ T cells in the sensitization led to pulmonary OX40L augmentation after the allergen challenge, which stimulated pulmonary NKT cells through OX40 to provide the pathogenic cytokine milieu. This was ablated by OX40L blockade by inhalation of the neutralizing antibody during the challenge, suggesting the therapeutic potential of targeting pulmonary OX40-OX40L interactions. Moreover, OX40 expression in CD4+ T cells, but not in NKTcells, was reciprocally regulated by the helper T cell type 1-skewing transcription factor Runx3. Conclusions: OX40 on not only CD4 + T cells but also NKT cells is involved in allergic airway inflammation. Notably, pulmonary blockade of OX40 ligation on NKT cells has therapeutic implications.
AB - Rationale: OX40-OX40 ligand (OX40L) interactions have been proposed to support induction of allergic airway inflammation, which may be attributable to OX40 signaling in CD4+ helper T cells for adaptive immune responses. However, a possible involvement of natural killer T (NKT) cells in the pathogenesis suggests that the underlying mechanisms are not yet fully elucidated. Objectives: We aimed to characterize the OX40-modulated cellular contribution to allergic airway inflammation in a mouse model of house dust mite (HDM) allergen exposure. Methods: Mice were sensitized to HDM and, 3 weeks later, challenged with HDM on three consecutive days through the airways. Two days after the last exposure, bronchoalveolar lavage fluids and blood samples and lung tissues were evaluated for the airway inflammation. Measurements and Main Results: The development of HDM-induced eosinophilic airway inflammation was dependent on OX40 of both CD4+ T cells and NKT cells; OX40 engagement on CD4+ T cells in the sensitization led to pulmonary OX40L augmentation after the allergen challenge, which stimulated pulmonary NKT cells through OX40 to provide the pathogenic cytokine milieu. This was ablated by OX40L blockade by inhalation of the neutralizing antibody during the challenge, suggesting the therapeutic potential of targeting pulmonary OX40-OX40L interactions. Moreover, OX40 expression in CD4+ T cells, but not in NKTcells, was reciprocally regulated by the helper T cell type 1-skewing transcription factor Runx3. Conclusions: OX40 on not only CD4 + T cells but also NKT cells is involved in allergic airway inflammation. Notably, pulmonary blockade of OX40 ligation on NKT cells has therapeutic implications.
KW - Environmental illness
KW - Inhalation therapy
KW - Neutralizing antibodies
UR - http://www.scopus.com/inward/record.url?scp=77951936959&partnerID=8YFLogxK
U2 - 10.1164/rccm.200910-1598OC
DO - 10.1164/rccm.200910-1598OC
M3 - Article
C2 - 20019337
AN - SCOPUS:77951936959
SN - 1073-449X
VL - 181
SP - 688
EP - 698
JO - American Journal of Respiratory and Critical Care Medicine
JF - American Journal of Respiratory and Critical Care Medicine
IS - 7
ER -